Several earlier studies reported that CD41+CD42d+ MKs and CD34+ stem/progenitor cells are severally impaired due to their interactions with tumor cells, stromal cells or soluble cytokines, leading to the impairment of MK differentiation31,32. The gene discussed is ITGA2B; the disease is neoplasm.